And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is exceedingly modest, however. We plan to hang with one of our short people, catch up on some reading, and check in on the Pharmalot ancestors. And what about you? Spring is now — finally — here, so you can start cleaning out your castle, manicuring the grounds, and, hopefully, enjoy some time in the great outdoors. Speaking of which, perhaps you want to check on the extent to which those of you situated near certain bodies of water may be affected by climate change, assuming you believe in that sort of thing. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon. …

President Trump’s ability to get his revised North American Free Trade Agreement through Congress may hinge on a little-noticed provision governing intellectual property protections for new medicines, the New York Times writes. Congressional Democrats have seized on measures in the United States-Mexico-Canada Agreement that establishes protections for drug makers, saying they are a boon to the pharmaceutical industry and could undermine efforts to make American health care more affordable.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy